StockData
NewcelX Ltd. logo

NewcelX Ltd. (NCEL) stock

NCELNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 29, 2026Score 4/30
$2.54−0.15 (-5.58%)

Close on Nov 20, 2026Market cap $12.19MP/E 1.2Yield –

NewcelX EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

For fiscal 2025 it was $2.16, down 11.1% from the year before. The highest annual figure on record is $2.43 in fiscal 2024.

Annual eps

PeriodPeriod endValueChange
FY2025Dec 31, 2025$2.16-11.1%
FY2024Dec 31, 2024$2.43+115.0%
FY2023Dec 31, 2023$1.13–
FY2022Dec 31, 2022-$33.52–
FY2021Dec 31, 2021-$40.00–
FY2020Dec 31, 2020-$16.40–

More NewcelX figures

See a number that looks wrong?